Tien-Li Lee - 09 Feb 2026 Form 4 Insider Report for Aardvark Therapeutics, Inc. (AARD)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Nelson Sun, as Attorney-in-Fact
Issuer symbol: AARD
Transactions as of: 09 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 11 Feb 2026, 21:00:15 UTC
Previous filing: 12 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Lee Tien-Li	Chief Executive Officer, Director, 10%+ Owner	C/O AARDVARK THERAPEUTICS, INC., 4370 LA JOLLA VILLAGE DRIVE, SUITE 1050, SAN DIEGO	/s/ Nelson Sun, as Attorney-in-Fact	11 Feb 2026	0001940120

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AARD	Stock option (right to buy)	Award	$0	-203,851	-50%	$0.000000	203,851	09 Feb 2026	Common Stock	203,851	$13.48	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/4th of the shares subject to the option shall vest on February 9, 2027, and 1/48th of the shares subject to the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.